English | 简体中文 | 繁體中文 | 한국어
 All Press Releases
 Medicine BioTech
君圣泰医药三项创新研究成果即将亮相2025欧肝会(EASL)
Apr 24, 2025 18:35 HKT
Everest Medicines Announces Approval of 'B' Marker Removal from Company's Stock Code by the Hong Kong Stock Exchange
Apr 22, 2025 10:16 HKT
雲頂新耀「摘B」成功 盈利能力與創新價值獲雙重驗證
Apr 22, 2025 10:12 HKT
云顶新耀"摘B"成功 盈利能力与创新价值获双重验证
Apr 22, 2025 10:11 HKT
CIRC: Attained a New High in Fiscal Year 2024
Apr 22, 2025 09:52 HKT
中國同輻2024財年再創新高
Apr 22, 2025 09:25 HKT
中国同辐2024财年再创新高
Apr 22, 2025 09:16 HKT
analytica Vietnam 2025 Concludes with Record-Breaking Attendance and Exhibitor Participation
Apr 16, 2025 23:55 HKT
熊去氧胆小檗碱(HTD1801)一药多效 即将进入商业化新纪元
Apr 15, 2025 08:10 HKT
熊去氧膽小檗堿(HTD1801)一藥多效 即將進入商業化新紀元
Apr 15, 2025 08:10 HKT
Berberine Ursodeoxycholate (HTD1801) Consistently Demonstrates Comprehensive Benefits for Patients with Type 2 Diabetes Mellitus, Approaching NDA
Apr 15, 2025 08:00 HKT
Hebe Biotechnology Appoints Industry Insider Dr. Hannes Hentze as Chief Development Officer to Advance Next-Generation GLP-1 RA Weight Loss Therapy
Apr 10, 2025 12:57 HKT
中國抗體製藥有限公司SM17治療特應性皮炎1b期概念驗證臨床試驗取得突破性結果
Apr 09, 2025 14:41 HKT
中国抗体制药有限公司SM17治疗特应性皮炎1b期概念验证临床试验取得突破性结果
Apr 09, 2025 14:30 HKT
Avantor Recognized with Two Prestigious Awards at Asia-Pacific Biopharma Excellence Awards 2025
Apr 03, 2025 17:00 HKT
華領醫藥公佈2024年全年業績
Mar 28, 2025 21:38 HKT
华领医药公布2024年全年业绩
Mar 28, 2025 21:28 HKT
歸母淨利潤首超20億 麗珠集團如何煉成「集采免疫術」
Mar 28, 2025 18:37 HKT
Revenue Soars with 137% Year-on-Year Growth, Multiple Products Poised for Launch, CanSinoBIO's Growth Momentum Strong
Mar 25, 2025 23:34 HKT
收入狂飙同比增长137% 多款产品蓄势以待 康希诺增长动能充沛
Mar 25, 2025 23:22 HKT
<< Previous  Next >>
Copyright © 2026 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: